investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Identification and validation of synthetic lethality in KRAS mutant lung adenocarcinoma patient derived xenografts

Charles M. Rudin

0 Collaborator(s)

Funding source

National Institutes of Health (NIH)

No posts

Related projects

Brid Ryan

Examining Novel Roles of Nicotine and Tobacco Smoke on RNA Biology

Trachea, bronchus and lung

Pathology

Srikumar P. Chellappan

TBK1 mediated regulation of E2F1 as a therapeutic target in non-small cell lung cancer

Trachea, bronchus and lung

Curtis Harris

Integrative Molecular Epidemiology of Human Cancer

Trachea, bronchus and lung

Hematology and hematologic malignancies

Pinar Ozden Eser

EGFR T790M-mediated drug resistance in non-small cell lung cancer

Trachea, bronchus and lung

Kelley Lee

Tobacco Companies, Public Policy and Global Health

Trachea, bronchus and lung

Munira Basrai

Molecular Determinants of Chromosome Transmission and Cell Cycle Regulation

Trachea, bronchus and lung

Pasi A Janne

Targeting RET in Lung Cancer

Trachea, bronchus and lung

Pathology

Gregory J Hannon

Cold Spring Harbor Laboratory Cancer Research Center

Trachea, bronchus and lung

Characterization of the Biological Activities of Novel Epigenetic Modulators

Trachea, bronchus and lung

Pathology